These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5867937)

  • 21. [Some data on the general pharmacology of glycoside SK].
    Angarskaia MA; Bezruk PI
    Farm Zh; 1968; 23(3):68-72. PubMed ID: 5703329
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of cardiotoxicity of cardiac glycosides in the cat. II. Method of intravenous and intraduodenal infusion assay, planning, execution and evaluation of screening tests].
    Lenke D; Schneider B
    Arzneimittelforschung; 1970 Sep; 20(9):1199-206. PubMed ID: 5536796
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relation between chemical structure and chromatographic behavior of cardiac glycosides. IV. Preparation and structure analysis of new partially acetylated gitoxines].
    Nover L
    Arch Pharm Ber Dtsch Pharm Ges; 1969 May; 302(5):321-34. PubMed ID: 5273057
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of the quantity of glucoside injected and its toxicity for cats, according to the method of Hatcher-Magnus].
    ALDAY REDONNET T
    Farmacognosia; 1951; 11(22):375-417. PubMed ID: 14954943
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipophilic character of cardiac glycosides: correlation between RM values and acute toxicity data in different animal species.
    Biagi GL; Guerra MC; Barbaro AM; Sapone A; Recantini M
    J Chromatogr; 1991 Jun; 547(1-2):523-30. PubMed ID: 1894729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiotonic properties of formiloxin a semi-synthetic cardiac glycoside.
    Georges A; Page J; Duvernay G
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):47-55. PubMed ID: 5972315
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of intermediate metabolic changes in the mechanism of cardiac insufficiency and cardiac glycoside toxicity].
    Pogosian LA
    Zh Eksp Klin Med; 1965; 5(3):31-6. PubMed ID: 5847709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pecularity in the structure of aglycones of cardiac glycosides with hexa-lactone cycle].
    Shilov IuM; Kotov AV; Zaĭtseva TM
    Farmatsiia; 1972; 21(3):82-5. PubMed ID: 5035658
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of dichloroisoproterenol (DCI) on the infusion toxicity of cardiac glycosides].
    Sziegoleit W; Förster W
    Experientia; 1964 Apr; 20(4):229-30. PubMed ID: 4379123
    [No Abstract]   [Full Text] [Related]  

  • 30. Chromatography on lipophilic dextran gels for fractionation of low molecular weight compounds II: separation of cardiac glycosides from cardiac aglycones.
    El-Olemy MM; Stohs SJ
    J Pharm Sci; 1975 Jan; 64(1):163-4. PubMed ID: 1133694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [RESORPTION AND DEGRADATION OF CARDIAC GLYCOSIDES. 4. ON CARDENOLIDE GLYCOSIDES IN THE ANIMAL LIVER].
    GILLISSEN J; HOTOVY R; LINGNER K
    Arzneimittelforschung; 1964 Apr; 14():335-8. PubMed ID: 14238586
    [No Abstract]   [Full Text] [Related]  

  • 32. CARDIAC GLYCOSIDES; MODE OF ACTION.
    CHOWDHURY AK
    Indian Med J; 1965 Jan; 59():8-20. PubMed ID: 14270612
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quantitative relationship of strophantoside effect on frog heart to cardiac activity and glycoside concentration].
    WILBRANDT W; BRAWAND K; WITT PN
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 219(5):397-407. PubMed ID: 13099376
    [No Abstract]   [Full Text] [Related]  

  • 34. [Quantitative comparison of the positively inotropic and of the toxic effect of several cardiac glycosides].
    Klupp H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966 Jan; 252(4):314-31. PubMed ID: 4222840
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of ligation of biliary duct on the lethal dose of cardiac glycosides for cats and guinea pigs].
    Kusakari I; Uchida S
    Sapporo Igaku Zasshi; 1964 Sep; 26(3):114-8. PubMed ID: 5891183
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of toxic doses of cardiac glycosides on the content of ribonucleic acid and glycogen in the heart and liver of animals].
    Belova LF
    Farmakol Toksikol; 1968; 31(3):278-81. PubMed ID: 5698105
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of unithiol on the toxicity of cardiac glycosides].
    Golota LG
    Vrach Delo; 1972 Mar; 3():41-2. PubMed ID: 5046698
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrocardiographic indices of the comparative toxicities of cardiac glycosides].
    Belova LF; Turova AD
    Kardiologiia; 1973 Mar; 13(3):73-81. PubMed ID: 4123832
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of alpha adrenergic blocking agents on myocardial toxicity of cardiac glycosides in guinea-pigs.
    Mukherjee KC; Sur RN; Kar K; Dhawan BN
    Indian J Exp Biol; 1972 Jan; 10(1):16-9. PubMed ID: 4404706
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the chemical demonstration of cardiac steroids in the cadaver].
    RAUDONAT H
    Dtsch Z Gesamte Gerichtl Med; 1959-1960; 49():665-9. PubMed ID: 14436474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.